Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Working with a qualified healthcare provider helps ensure that the right compounds, dosages, and protocols are selected
NICE guideline NG49
Insurance does not cover peptide therapy
its specially treated to inhibit the growth of bacteria
Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
Researchers today believe that mitochondrial health is directly linked to our aging processes and the resistance of cells to degenerative diseases
